Nykode Therapeutics AS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	51.28	60.29	115.4	162.6	206.39	216.23
Trading Asset Securities	-	-	-	-	-	12.17
Cash & Short-Term Investments	51.28	60.29	115.4	162.6	206.39	228.4
Cash Growth	-51.73%	-47.76%	-29.03%	-21.21%	-9.64%	9.39%
Accounts Receivable	-	-	-	-	2.54	23.75
Other Receivables	4.03	0.91	0.91	1.07	1.79	2.41
Receivables	4.03	0.91	0.91	1.07	4.33	26.16
Prepaid Expenses	-	0.7	0.76	2.01	1.15	1.3
Total Current Assets	55.32	61.89	117.07	165.68	211.87	255.86
Property, Plant & Equipment	5.1	5.68	7.74	10.52	9.53	9.17
Other Intangible Assets	0.07	0.07	0.07	0.07	0.03	0.03
Long-Term Deferred Tax Assets	0.08	0.08	-	-	-	-
Long-Term Deferred Charges	-	-	-	-	-	0.48
Other Long-Term Assets	33.31	32.22	28.6	31.92	0.05	0.02
Total Assets	93.87	99.96	153.48	208.19	221.48	265.56
Accounts Payable	2.18	1.11	0.86	1.33	2.31	2.75
Accrued Expenses	-	3.37	3.62	6.08	7.58	9.3
Current Portion of Leases	1.3	1.25	1.29	1.46	1.15	1.35
Current Income Taxes Payable	-	-	0.02	-	0.08	0.03
Current Unearned Revenue	-	-	-	8.34	19.87	16.26
Other Current Liabilities	0.89	0.46	3.3	3.41	8	1.69
Total Current Liabilities	4.37	6.19	9.1	20.61	38.99	31.37
Long-Term Leases	1.03	1.3	2.15	4.27	4.37	5.82
Long-Term Deferred Tax Liabilities	-	-	5.2	12.05	21.08	29.4
Other Long-Term Liabilities	0.96	0.93	0.82	0	0.03	4.91
Total Liabilities	6.36	8.42	17.27	36.93	64.46	71.5
Common Stock	0.37	0.37	0.37	0.37	0.34	0.33
Additional Paid-In Capital	96.71	96.71	128.99	128.99	83.32	81.53
Retained Earnings	-25.3	-21.18	-8.76	29.56	64.71	107.46
Comprehensive Income & Other	15.74	15.65	15.62	12.35	8.65	4.74
Shareholders' Equity	87.51	91.54	136.21	171.26	157.02	194.06
Total Liabilities & Equity	93.87	99.96	153.48	208.19	221.48	265.56
Total Debt	2.33	2.55	3.44	5.73	5.51	7.17
Net Cash (Debt)	48.95	57.74	111.96	156.88	200.87	221.23
Net Cash Growth	-52.45%	-48.43%	-28.63%	-21.90%	-9.20%	6.10%
Net Cash Per Share	0.15	0.18	0.34	0.52	0.69	0.77
Filing Date Shares Outstanding	326.55	326.55	326.55	326.55	294.69	289.62
Total Common Shares Outstanding	326.55	326.55	326.55	326.55	294.69	289.62
Working Capital	50.95	55.7	107.97	145.07	172.89	224.49
Book Value Per Share	0.27	0.28	0.42	0.52	0.53	0.67
Tangible Book Value	87.44	91.47	136.14	171.19	156.99	194.02
Tangible Book Value Per Share	0.27	0.28	0.42	0.52	0.53	0.67
Machinery	-	5.03	5.02	4.97	3.44	1.46